Viz.ai Launches Ai-powered Viz Pulmonary Suite
The new suite integrates workflows for COPD, lung nodules, and pulmonary embolism to improve patient follow-up and treatment times.
Tag: pulmonary embolism and VTE/DVT
All
Latest
Viz.ai Launches Ai-powered Viz Pulmonary Suite
The new suite integrates workflows for COPD, lung nodules, and pulmonary embolism to improve patient follow-up and treatment times.
Read More
Ai Matches Radiologists in Detecting Pulmonary Embolism
A study of more than 32,000 CTPA scans found that artificial intelligence and physicians agreed on pulmonary embolism results nearly 98% of the time, though human review caught cases the software missed.
Read More
Asundexian Lowered Stroke Risk Without Increased Bleeding Complications
Bayer AG’s investigational drug asundexian reduced recurrent stroke risk by 26% in patients who recently experienced a stroke or temporary blockage of blood flow.
Read More
Endovascular Therapy Improved QoL for DVT Patients with Chronic Blood Clot Complications
A clinical trial found that minimally invasive endovascular therapy reduces symptoms of post-thrombotic syndrome after deep vein thrombosis.
Read More
First AHA/ACC Guidelines for Managing Pulmonary Embolism
The American Heart Association and American College of Cardiology issued their first joint clinical practice recommendations for acute pulmonary embolism.
Read More
International Space Station Studies Respiratory, and Exercise Science
NASA’s Expedition 74 crew wrapped up the week with cardiac and respiratory studies and conducting space exercise research to keep astronauts healthy off the Earth.
Read More
Researchers ID Cause of Blood Clots After COVID Vaccines, Infections
Scientists have identified why some patients developed dangerous blood clots called vaccine-induced immune thrombocytopenia and thrombosis (VITT) after receiving certain COVID‑19 vaccines, or after natural adenovirus infection.
Read More
New Guidance Issued for Coagulation Testing in Patients on Blood Thinners
The ADLM issued guidance for coagulation testing in patients using direct oral anticoagulants (DOACs), including stroke, deep vein thrombosis, and pulmonary embolism.
Read More
COVID-19 May Increase VTE Risks for Panniculectomy
Researchers caution that COVID-19 history is an “additional risk factor” for VTE in patients undergoing panniculectomy to remove excess abdominal skin.
Read More
Pulmonary Embolism as Common in Children as Adults
A study of over 4,000 children found an unexpectedly high frequency of pulmonary embolism—equal to rates seen in adults.
Read More
SonoThrombectomy Ultrasound System Shows Promise as Embolism Therapy
SonoVascular Inc’s SonoThrombectomy System is a catheter-based system that delivers ultrasound energy, microbubbles and thrombolytic drug to break down blood clots via an integrated mechanical-pharmacological approach.
Read More
sCD13 Protein Tied to Severe Complications in COVID-19
Elevated sCD13 levels in COVID-19 patients’ lungs are associated with severe complications like respiratory failure and blood clot formation.
Read More
Future NBA Hall of Famer Damian Lillard Out With DVT
An NBA all-star for the Milwaukee Bucks will miss the remainder of the NBA regular season after being diagnosed with deep vein thrombosis (DVT).
Read More
Preventing and Recognizing Pediatric Emboli
Cardiorespiratory specialists warn discuss warning signs for pediatric emboli, which are on the rise, they say.
Read More
Air Pollution Tied to Venous Thromboembolism (VTE)
Greater exposure to long-term air pollution was linked with increased risks for venous thromboembolism — blood clots that can occur in deep veins.
Read More
NBA Star Victor Wembanyama Diagnosed with DVT
The San Antonio Spurs report center Victor Wembanyama has been diagnosed with deep vein thrombosis (DVT) in his shoulder and will miss the rest of the NBA’s regular season.
Read More
Trial Launches to Test Novel Device for Treating Pulmonary Embolism
Argon Medical Devices has enrolled the first patient in a US-based study exploring a novel catheter-based device for managing blood clots in the lungs.
Read More
Higher Anticoagulant Doses Reduce Mortality in Hospitalized COVID-19 Patients
A therapeutic dose of anticoagulation with herapins also reduced the need for mechanical ventilation and the risk of thromboembolic events.
Read More
Air Pollution Linked to Increased Risk of Venous Thromboembolism
The likelihood of VTE was linked to anywhere from a 39% to a more than two-fold increased risk based on long-term exposure to three different types of air pollutants.
Read More
New Dye-Free Imaging Software Could Help Patients Allergic to Contrast Dye
The CT-derived functional imaging software provides lung diagnostics without the need for contrast dye, which could benefit up to 30% of patients allergic to dye or with dye restrictions.
Read More
FDA Clears AlphaVac F1885 System for Treatment of Pulmonary Embolism
The clearance broadens the applicability of the AlphaVac F1885 System in the non-surgical removal of thrombi or emboli from the venous vasculature.
Read More
Most Low-risk Pulmonary Embolism Patients Still Hospitalized After ED Visit
The trend of hospitalizing low-risk PE patients continues despite evidence supporting safe outpatient care, according to a new analysis.
Read More
Endovascular Catheter Opens Blocked Arteries Deep Within Lungs
New research shows an endovascular catheter, recently approved by the FDA and already shown to be effective in reducing blockages in lung arteries, also reduces blockages in the smaller segmental pulmonary artery branches.
Read More
Nirmatrelvir–Ritonavir Ineffective for Most Post-COVID Conditions
A trial emulation study of veterans with COVID-19 found that the use of the antiviral nirmatrelvir–ritonavir (Paxlovid) was not effective for reducing the risk for many post-COVID-19 conditions.
Read More